These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21110822)

  • 1. Informatics of drug synergism in naturally occurring anticancer agents.
    Ghavami G; Kazemali MR; Sardari S
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):26-44. PubMed ID: 21110822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer combination therapies with artemisinin-type drugs.
    Efferth T
    Biochem Pharmacol; 2017 Sep; 139():56-70. PubMed ID: 28366726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cheminformatics-based selection and synergism of herbal extracts with anticancer agents on drug resistance tumor cells-ACHN and A2780/cp cell lines.
    Ghavami G; Sardari S; Ali Shokrgozar M
    Comput Biol Med; 2011 Aug; 41(8):665-74. PubMed ID: 21752359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies.
    Jang B; Kwon H; Katila P; Lee SJ; Lee H
    Adv Drug Deliv Rev; 2016 Mar; 98():113-33. PubMed ID: 26654747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant Polyphenolic Compounds Potentiates Therapeutic Efficiency of Anticancer Chemotherapeutic Drugs: A Review.
    Oruganti L; Meriga B
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):246-252. PubMed ID: 32767950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
    Karthikeyan S; Hoti SL
    Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Therapy and the Evolution of Resistance: The Theoretical Merits of Synergism and Antagonism in Cancer.
    Saputra EC; Huang L; Chen Y; Tucker-Kellogg L
    Cancer Res; 2018 May; 78(9):2419-2431. PubMed ID: 29686021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy.
    Banudevi S; Swaminathan S; Maheswari KU
    Nutr Cancer; 2015; 67(7):1021-48. PubMed ID: 26359767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential and cytotoxicity of cis-platinum complex with anti-tumor activity in combination therapy.
    Ho JW
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):129-34. PubMed ID: 18221032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural compounds and combination therapy in colorectal cancer treatment.
    Rejhová A; Opattová A; Čumová A; Slíva D; Vodička P
    Eur J Med Chem; 2018 Jan; 144():582-594. PubMed ID: 29289883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of phytochemicals as adjuvants for cancer therapy.
    Ho JW; Cheung MW
    Recent Pat Anticancer Drug Discov; 2014; 9(3):297-302. PubMed ID: 24942759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DrugComb: an integrative cancer drug combination data portal.
    Zagidullin B; Aldahdooh J; Zheng S; Wang W; Wang Y; Saad J; Malyutina A; Jafari M; Tanoli Z; Pessia A; Tang J
    Nucleic Acids Res; 2019 Jul; 47(W1):W43-W51. PubMed ID: 31066443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
    Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?
    Catanzaro E; Calcabrini C; Turrini E; Sestili P; Fimognari C
    Expert Opin Ther Targets; 2017 Aug; 21(8):781-793. PubMed ID: 28675319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic Stilbenes and Derivatives as Promising Antimitotic Leads for Cancer Therapy.
    Faustino C; Francisco AP; Isca VMS; Duarte N
    Curr Pharm Des; 2018; 24(36):4270-4311. PubMed ID: 30636588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism.
    Mak L; Liggi S; Tan L; Kusonmano K; Rollinger JM; Koutsoukas A; Glen RC; Kirchmair J
    Curr Pharm Des; 2013; 19(4):532-77. PubMed ID: 23016852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.